Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-001003
Filing Date
2025-02-14
Accepted
2025-02-14 14:30:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9007
2 JOINT FILING AGREEMENT p25-0497exhibit99_1.htm EX-99.1 4466
  Complete submission text file 0000902664-25-001003.txt   15243
Mailing Address PAUL EHRLICH-STRASSE 15 TUBINGEN 2M 72076
Business Address PAUL EHRLICH-STRASSE 15 TUBINGEN 2M 72076 49 7071 5397 700
Immatics N.V. (Subject) CIK: 0001809196 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91607 | Film No.: 25626840
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 632 BROADWAY SUITE 602 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 602 NEW YORK NY 10012 6469894000
Vestal Point Capital, LP (Filed by) CIK: 0001974915 (see all company filings)

EIN.: 922296021 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G